Literature DB >> 6527374

The development of respiratory syncytial virus-specific immune complexes in nasopharyngeal secretions following natural infection.

T N Kaul, R C Welliver, H S Faden, P L Ogra.   

Abstract

Sequential samples of nasopharyngeal secretions (NPS) from 61 infants and children with respiratory syncytial virus (RSV) infection were examined for the presence of RSV-specific immune complexes in order to determine their possible role in recovery from or pathogenesis of RSV infection. Immune complexes in NPS were identified by the Raji cell assay using indirect immunofluorescence and RSV antigen in these complexes was also detected by indirect immunofluorescence. RSV-specific immune complexes were detected in 56% of subjects tested, being present as early as 3-6 days after the onset of illness and persisting for up to 36 days after the onset of illness. The appearance of immune complexes was temporally associated with the disappearance of RSV antigen from airway epithelial cells, suggesting a role for immune complexes in eradication of infection. RSV-specific immune complexes were identified with approximately equal frequency in patients with all forms of illness due to RSV, an observation which tends to rule out a role for immune complexes in the pathogenesis of RSV disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6527374

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  3 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection.

Authors:  M L Everard; A Swarbrick; M Wrightham; J McIntyre; C Dunkley; P D James; H F Sewell; A D Milner
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

Review 3.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.